LS
Lang Sheng Investment
Venture CapitalActiveLang Sheng Investment is a life science and big data investment firm in China.
15
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Lang Sheng Investment.
Investment Thesis & Strategy
Lang Sheng Investment invests in various stages of fintech and venture capital companies in China, with a focus on life science and big data.
Investment Activity
Deals per year over the last 4 years
2
20164
20174
20182
2019Portfolio Companies
Selected investments from their portfolio of 15 companies
A
Adlai Nortye
Biotech · Series B, 2019
L
Lepu Biopharma
Biotech · Series B, 2019
S
Singlera Genomics
Biotech · Series B, 2018
R
RemeGen
Biotech · Series B, 2018
3
3D Medicines
Biotech · Series B, 2018
E
Elpiscience
Biotech · Series B, 2018
Z
Zhejiang Weiming Environment Protection
Cleantech · Growth, 2017
V
Vcanbio
Biotech · Series A, 2017
G
Geneplus
Biotech · Series B, 2017
N
New Horizon Health
Healthcare · Series B, 2017
G
GenomiCare
Biotech · Series A, 2016
C
CStone Pharmaceuticals
Biotech · Series B, 2016
Frequently Asked Questions
Lang Sheng Investment focuses on Series A, Series B, Series C+ stage investments.